2 mA transcranial direct current stimulation (tDCS) for Attention Deficit Hyperactivity Disorder (ADHD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Massachusetts General Hospital, Charlestown, MAAttention Deficit Hyperactivity Disorder (ADHD)+1 More2 mA transcranial direct current stimulation (tDCS) - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a home-based tDCS device can help improve symptoms of ADHD and cognitive control over a four week period. They are also testing whether there is a dose-dependent response to tDCS.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Attention Deficit Hyperactivity Disorder (ADHD) - Inattentive Type

Video Summary

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: Week 1 - Week 8 of Study

Week 8
Adult ADHD Self-Report Scale
Global Assessment of Functioning (GAF) Scale
P300 Amplitude during Erickson Flanker Task

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

2mA transcranial direct current stimulation
1 of 3
1mA transcranial direct current stimulation
1 of 3
Sham transcranial direct current stimulation
1 of 3

Experimental Treatment

Non-Treatment Group

60 Total Participants · 3 Treatment Groups

Primary Treatment: 2 mA transcranial direct current stimulation (tDCS) · Has Placebo Group · N/A

2mA transcranial direct current stimulation
Device
Experimental Group · 1 Intervention: 2 mA transcranial direct current stimulation (tDCS) · Intervention Types: Device
1mA transcranial direct current stimulation
Device
Experimental Group · 1 Intervention: 1 mA transcranial direct current stimulation (tDCS) · Intervention Types: Device
Sham transcranial direct current stimulation
Device
ShamComparator Group · 1 Intervention: Sham transcranial direct current stimulation (tDCS) · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 1 - week 8 of study

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,737 Previous Clinical Trials
31,217,365 Total Patients Enrolled
58 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
7,973 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Joan Camprodon, MD, PHD, MPHPrincipal InvestigatorMGB: Division of Neuropsychiatry and Neuromodulation

Eligibility Criteria

Age 18 - 65 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD) based on DSM-5 criteria.

Who else is applying?

What state do they live in?
Massachusetts27.3%
Washington9.1%
Pennsylvania9.1%
Other54.5%
How old are they?
18 - 65100.0%
What site did they apply to?
Massachusetts General Hospital100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria41.7%
Met criteria58.3%
Why did patients apply to this trial?
  • "I want to learn more about my disease and by contributing, we will be able to gain more insight."
  • "I've tried ADHD medications along with therapy and while I have received some benefit, I still have major struggles with executive function, motivation, distractibility, among others."
How many prior treatments have patients received?
050.0%
125.0%
3+25.0%
What questions have other patients asked about this trial?
  • "Do participants need to travel to the site?"

Frequently Asked Questions

Does this research include geriatric participants?

"This research project is seeking participants aged 18 to 65." - Anonymous Online Contributor

Unverified Answer

Are there any available slots for participants in this research trial?

"Affirmative. The details found on clinicaltrials.gov suggest that this research project is presently recruiting individuals for the trial, which was first made public on July 1st 2022 and has been refreshed as recently as July 21st 2022. Sixty people are required to be enrolled at one medical site." - Anonymous Online Contributor

Unverified Answer

Could I potentially join this clinical trial?

"This clinical trial is seeking 60 male and female outpatients between the ages of 18-65 to participate. All potential enrollees must have been diagnosed with Attention Deficit Hyperactivity Disorder - Inattentive Type, or meet the criteria outlined in DSM-5 for such a diagnosis." - Anonymous Online Contributor

Unverified Answer

How many participants are accepted in this clinical trial?

"Affirmative, clinicaltrials.gov reports that this examination is currently enrolling participants. The trial was first advertised on July 1st 2022 and has since had its details amended. 60 volunteers are required from a single medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.